Catalog No.:AA002LZE

230618-41-4 | 2-Bromo-6-(pyrrolidin-1-yl)pyridine

Name: Name:2-Bromo-6-(pyrrolidin-1-yl)pyridine
Brand: AABLOCKS
SKU: AA002LZE
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

250mg

98%

in stock

$22.00 $15.00

- +

98%

in stock

$46.00 $32.00

- +

98%

in stock

$158.00 $110.00

- +

100g

98%

in stock

$2,007.00 $1,405.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA002LZE

Chemical Name:

2-Bromo-6-(pyrrolidin-1-yl)pyridine

CAS Number:

230618-41-4

Molecular Formula:

C9H11BrN2

Molecular Weight:

227.1010

MDL Number:

MFCD08271892

SMILES:

Brc1cccc(n1)N1CCCC1

Properties

Computed Properties

Complexity:

146

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Rotatable Bond Count:

XLogP3:

2.8

Downstream Synthesis Route

123-75-1

626-05-1

230618-41-4

[1]Sammakia,Tarek;Hurley,T.Brian[JournalofOrganicChemistry,1999,vol.64,#13,p.4652-4664]

[2]CurrentPatentAssignee:UCB-WO2010/52448,2010,A2Locationinpatent:Page/Pagecolumn42

[3]Basu,Basudeb;Jha,Satadru;Mridha,NiranjanK.;Bhuiyan,Md.MosharefH.[TetrahedronLetters,2002,vol.43,#44,p.7967-7969]

[4]Locationinpatent:experimentalpartBasu,Basudeb;Das,Sajal;Mandal,Bablee[IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2008,vol.47,#11,p.1701-1706]

[5]CurrentPatentAssignee:NORTHEASTERNUNIVERSITYINBOSTON,MASSACHUSETTS-WO2015/27160,2015,A2Locationinpatent:Paragraph0175

[6]Kulkarni,PushkarM.;Kulkarni,AbhijitR.;Korde,Anisha;Tichkule,RiteshB.;Laprairie,RobertB.;Denovan-Wright,EileenM.;Zhou,Han;Janero,DavidR.;Zvonok,Nikolai;Makriyannis,Alexandros;Cascio,MariaG.;Pertwee,RogerG.;Thakur,GaneshA.[JournalofMedicinalChemistry,2016,vol.59,#1,p.44-60]

[7]Bolliger,JeanneL.;Oberholzer,Miriam;Frech,ChristianM.[AdvancedSynthesisandCatalysis,2011,vol.353,#6,p.945-954]

[8]German,Nadezhda;Decker,AnnM.;Gilmour,BrianP.;Gay,ElaineA.;Wiley,JennyL.;Thomas,BrianF.;Zhang,Yanan[JournalofMedicinalChemistry,2014,vol.57,#18,p.7758-7769]

[9]CurrentPatentAssignee:ASTELLASPHARMAINC.-WO2006/18662,2006,A2Locationinpatent:Page/Pagecolumn31

[10]CurrentPatentAssignee:NEUROPORETHERAPIES-WO2022/67114,2022,A1Locationinpatent:Paragraph0285

[11]CurrentPatentAssignee:NEUROPORETHERAPIES-WO2022/67114,2022,A1Locationinpatent:Paragraph0285

93267-04-0

230618-41-4

(2S)-(N-tert-butoxycarbonylamino)-3-(6'-pyrrolidin-1'-yl-pyridine)propionicacidmethylester

[1]Tabanella,Stefania;Valancogne,Ingrid;Jackson,RichardFW[Organicandbiomolecularchemistry,2003,vol.1,#23,p.4254-4261]

230618-41-4

(2S)-(N-tert-butoxycarbonylamino)-3-(6'-pyrrolidin-1'-yl-pyridine)propionicacid

[1]Tabanella,Stefania;Valancogne,Ingrid;Jackson,RichardFW[Organicandbiomolecularchemistry,2003,vol.1,#23,p.4254-4261]

109-96-6

872-50-4

626-05-1

(3R)-3-2-Benzyl-6-(cis-3,4-dimethoxyprrolidine-1-yl)-3-pyridylethynyl-3-quinuclidinol

230618-41-4

[1]CurrentPatentAssignee:EISAICOLTD-US6599917,2003,B1

13331-27-6

230618-41-4

877201-65-5

[1]CurrentPatentAssignee:NORTHEASTERNUNIVERSITYINBOSTON,MASSACHUSETTS-WO2015/27160,2015,A2Locationinpatent:Paragraph0175

[2]Kulkarni,PushkarM.;Kulkarni,AbhijitR.;Korde,Anisha;Tichkule,RiteshB.;Laprairie,RobertB.;Denovan-Wright,EileenM.;Zhou,Han;Janero,DavidR.;Zvonok,Nikolai;Makriyannis,Alexandros;Cascio,MariaG.;Pertwee,RogerG.;Thakur,GaneshA.[JournalofMedicinalChemistry,2016,vol.59,#1,p.44-60]

[3]German,Nadezhda;Decker,AnnM.;Gilmour,BrianP.;Gay,ElaineA.;Wiley,JennyL.;Thomas,BrianF.;Zhang,Yanan[JournalofMedicinalChemistry,2014,vol.57,#18,p.7758-7769]

[4]CurrentPatentAssignee:ASTELLASPHARMAINC.-WO2006/18662,2006,A2Locationinpatent:Page/Pagecolumn31

Literature

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS